Recruiting
Phase 2

Pemigatinib

Sponsor:

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Code:

NCT03914794

Conditions

Bladder Cancer

NMIBC

Non-Muscle Invasive Bladder Cancer

Urothelial Carcinoma Recurrent

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Pemigatinib

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information